Insider · CIK 0001091222
Stephen C Kircher
Files at NTRP (NextTrip, Inc.). First filing -, latest -.
In brief
Stephen C Kircher files SEC Form 4 as director at NTRP (NextTrip, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Stephen C Kircher has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 21, 2025 | NTRP NextTrip, Inc. | CConversion Common Stockindirect: By The Kircher Family Trust | +34,223 | $0.00 | $0 | 47,501 | Nov 25, 2025 |
| Nov 21, 2025 | NTRP NextTrip, Inc. | CConversion Series Q Nonvoting Convertible Preferred Stockderivativeindirect: By The Kircher Family Trust | +34,223 | $0.00 | $0 | 0 | Nov 25, 2025 |
| Sep 15, 2025 | NTRP NextTrip, Inc. | JOther Series Q Nonvoting Convertible Preferred Stockderivative | +34,223 | $3.20 | $110k | 34,223 | Nov 6, 2025 |
Questions about Stephen C Kircher
Answered from the filings on this page, as of the latest one.
Is Stephen C Kircher buying or selling?
Stephen C Kircher has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Stephen C Kircher's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Stephen C Kircher has 0.
Where does Stephen C Kircher file Form 4?
Stephen C Kircher has filed Form 4 at NTRP (NextTrip, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.